Last reviewed · How we verify
NCT06141421
A Real-World Study to Evaluate the Clinical Performance and Safety of da Vinci SP Surgical System for Single-Port Colorectal Surgeries（SPiM-RWS-CR）
trial testing procedure in Single-Port Colorectal Surgeries in 15 participants. Completed in 15 August 2024.
15 August 2024
Quick facts
| Lead sponsor | Ruijin Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 15 |
| Start date | 28 March 2023 |
| Primary completion | 15 August 2024 |
| Estimated completion | 15 August 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- procedure
Conditions studied
- Single-Port Colorectal Surgeries — all drugs for Single-Port Colorectal Surgeries →
Sponsor
Ruijin Hospital
Who can join
Eligibility, any sex, with Single-Port Colorectal Surgeries. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A real-world study to evaluate the clinical performance and safety of da Vinci SP Surgical System ("SP single-port robot" for short) for single-port robot-assisted colorectal surgeries in the real world, providing a real world evidence for clinical application of the product in the Chinese population. English name: da Vinci SP Surgical System Model and specification: SP1098 Manufacturer: Intuitive Surgical, Inc.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Single-port robotic-assisted colorectal surgery using the da Vinci SP system: a preliminary noncomparative exploratory cohort study.
Huang C, Shi Y, Song Z, Gong X, et al · · 2026 · PMID 41247915 · DOI 10.1097/js9.0000000000003915
Verify or expand the search:
- PubMed search for NCT06141421
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of procedure
Trials testing the same drug.
- NCT03603483 — Aortic Root Enlargement in Aortic Valve Replacement · NA · unknown
- NCT02115100 — Treatment of Atrial Fibrillation in Patients by Pulmonary Vein Isolation in Combination With Renal Denervation or Pulmon · NA · completed
Other Ruijin Hospital trials
Trials by the same sponsor.
- NCT07589361 — Safety and Efficacy of Vertebral Body-Sparing Craniospinal Irradiation With Proton Therapy in Pediatric Tumors · not yet recruiting
- NCT07449507 — Partially Hydrolyzed Whey Protein Formula for Infants With Mild Allergy · NA · not yet recruiting
- NCT07496385 — Clinical Study on the Efficacy of Subglottic Suction in Mechanically Ventilated Patients Guided by Bedside Ultrasound · NA · not yet recruiting
- NCT07511114 — A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyp · Phase 3 · not yet recruiting
- NCT07514169 — The Efficacy and Safety of Pola-ZR-Glo in Older Treatment-naive Patients With LBCL · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06141421 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ruijin Hospital
- Last refreshed: 12 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06141421.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing